- Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial2018 | First Faculty of Medicine
- AT1-blockers in the treatment of hypertension: summary2016 | First Faculty of Medicine
- Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis2023 | Publication without faculty affiliation
- Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial2023 | First Faculty of Medicine